Focus Stocks
Trading Idea - Is Tenet Healthcare close to Support?
Published on Monday, 28 June 2010 05:56 Written by Christian Paolinetti
New York, June 28th (TradersHuddle.com) - Shares of Tenet Healthcare Corporation (NYSE:THC) are trading very close to calculated support at $4.67 with current price action closing at just $4.71 places the stock price near levels where traders will start paying attention.
Tenet Healthcare Corporation (NYSE:THC) owns or operates general hospitals and related health care facilities serving communities in the United States. The Dallas, Texas company operates rehabilitation hospitals, specialty hospitals, long-term care facilities, psychiatric facilities, and medical office buildings near its general hospitals, as well as ancillary health care businesses.
Tenet's current stock range is defined by current calculated support defined at $4.67 and by the resistance level at $5.28, which should be used by traders planning their trades.
Traders wanting to establish a position should place close attention to Tenet's price action, and establish a position as close to support as possible, but only after buying materializes. Traders should understand that the resistance point at $5.28 might limit their upside, however if the stock breaks resistance, it could be a good point to add to the position.
Related Articles
- Tenet to Report Fourth Quarter Results on February 28, 2012
- Tenet Announces New Agreement with Blue Cross and Blue Shield of Illinois
- Tenet Issues Outlook for 2012 Adjusted EBITDA
- Tenet Management to Present at the J.P. Morgan Annual Healthcare Conference on January 9th
- Tenet Names Britt T. Reynolds President of Hospital Operations
- Tenet Announces Completion of Cash Tender Offer for 9.0% Senior Secured Notes due 2015
- Stocks erase all Gains, End Flat (AAPL, BAC, BIG, BSX, DIS, HD, JPM, LULU, MS, RIMM, THC, WDC)
- Conifer Health Solutions Named a Centers for Medicare & Medicaid Services (CMS) Approved HCAHPS Survey Vendor
- Tenet Publishes First Corporate Sustainability Report
- Tenet Announces Doctors Medical Center Modesto Appoints New Hospital CEO
Related Partner Headlines
- Tenet Healthcare Corp (THC): Today's Featured Health Services Loser - TheStreet.com
- Tenet Healthcare Stock Hits New 52-Week Low (THC) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Benzinga's Top Pre-Market Gainers - Benzinga -
Resolute Forest Products Sees 2011 EPS of .71 vs .53 Est - Benzinga -
Wedbush Securities Upgrades ON Semiconductor from Neutral to Outperform, Raises PT from to .5 - Benzinga -
Stifel Nicolaus Maintains Visa at Buy, Raises PT from 5 to 6 - Benzinga -
Stifel Nicolaus Maintains SPS Commerce at Buy, Raises PT from to - Benzinga -
Stifel Nicolaus Maintains Selectmfort at Buy, Raises PT from to - Benzinga -
Stifel Nicolaus Maintains Roadrunner Trans at Buy, Raises PT from to - Benzinga -
Crocs Seeks Growth Opportunities in Brand Licensing - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
Sigma-Aldrich (NASDAQ: SIAL) Reports Diluted EPS of $0.89, a 17% Increase, and 5% Sales Growth for Q4 2011. Full Year 2011 Diluted EPS Increased 14%. 2012 Diluted EPS Expected to Increase to $3.90 to $4.05 -
Endologix Completes Enrollment in PEVAR Randomized Trial -
SRS Labs Partners With FMOD to Offer SRS 5.1 Surround Sound On Popular Gaming Platform -
Industrial Nanotech, Inc. Announces Successful Energy Saving Project with Textile Manufacturer Intem Triko -
David Colford Appointed as Geeknet Media's Executive Vice President of Global Sales and Operations -
Acetylon Announces $15 Million Strategic Equity Investment by Celgene Corporation -
Pacer International Reports Three Fold Increase in Income from Operations for the Fourth Quarter -
Alnylam Scientists Discover Novel Method for Monitoring RNAi Activity in Blood Samples










